Business Segments Brainlab SE

Stocks

BNLB

DE0005207906

End-of-day quote Deutsche Boerse AG Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-

02-25	Brainlab SE and Precision NeuroMed Announce Strategic Partnership to Standardize and Scale Precision Drug Delivery to the Brain	CI
20/10/25	Marine Shipbuilder TKMS Makes Spectacular Stock Market Debut	DP

Sales 2024 by Business Segment

Sales 2024 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (EUR)

Fiscal Period: September	2021	2022	2023	2024
Medical Testing, Analyzing, and Diagnostic Equipment
Spinal and Cranial Surgery	-	-	-	317M
Total Assets	-	-	-	333M
Interest Expense	-	-	-	-1.25M
CAPEX	-	-	-	-3.25M
EBT	-	-	-	54.11M
Gross Profit	-	-	-	200M
EBITDA	-	-	-	81.03M
Operating Income	-	-	-	54.95M
Radiosurgery	88.52M	92.28M	104M	111M
Total Assets	110M	124M	126M	130M
Interest Expense	-172K	-203K	-205K	-274K
CAPEX	-400K	-575K	-319K	-358K
EBT	8.76M	9.08M	10.64M	901K
Gross Profit	48.81M	53.03M	63.76M	61.81M
EBITDA	19.94M	19.62M	24.35M	17.72M
D&A	11.01M	10.34M	-	-
Operating Income	8.93M	9.28M	10.84M	1.04M
Other Surgery	-	-	-	25.56M
Total Assets	-	-	-	62.24M
Interest Expense	-	-	-	-863K
CAPEX	-	-	-	-508K
EBT	-	-	-	-5.36M
Gross Profit	-	-	-	16.24M
EBITDA	-	-	-	670K
Operating Income	-	-	-	-4.5M
Surgery	205M	203M	242M	-
Total Assets	180M	231M	255M	-
Interest Expense	-33K	-448K	-527K	-
CAPEX	-3.17M	-3.83M	-3.47M	-
EBT	66.68M	50.23M	64.43M	-
Gross Profit	141M	143M	170M	-
EBITDA	81.99M	65.04M	83.21M	-
D&A	15.28M	14.37M	-	-
Operating Income	66.71M	50.68M	64.95M	-
Healthcare Industry Software
Healthcare	-	-	-	24.24M
Total Assets	-	-	-	79.5M
Interest Expense	-	-	-	-99K
CAPEX	-	-	-	-218K
EBT	-	-	-	-45.74M
Gross Profit	-	-	-	15.54M
EBITDA	-	-	-	-21.81M
Operating Income	-	-	-	-45.65M
Digital Health	64.9M	68.95M	83.02M	-
Total Assets	160M	196M	204M	-
Interest Expense	-361K	-443K	-926K	-
CAPEX	-3.03M	-657K	-992K	-
EBT	-38.25M	-52.32M	-64.24M	-
Gross Profit	24.64M	20.64M	34.31M	-
EBITDA	-23.57M	-34.52M	-36.52M	-
D&A	14.32M	17.36M	-	-
Operating Income	-37.89M	-51.88M	-63.31M	-
Elimination of Inter-Segment Revenue	-	-	-	-7.93M
Gross Profit	-	-	-	7.93M
Gross Profit	-	-	-	-7.93M
D&A	-165K	3.39M	-	-
Operating Income	48K	56K	323K	43K
EBITDA	-114K	3.44M	4.35M	43K
EBT	-2.96M	-2.84M	-6.73M	-9.84M
CAPEX	-2.77M	-4.26M	-3.54M	-3.68M
Interest Expense	-3.01M	-2.9M	-7.05M	-10.31M
Total Assets	123M	116M	132M	129M

Geographical Revenue Distribution History

Geographical breakdown of sales (EUR)

Fiscal Period: September	2021	2022	2023	2024
USA	-	-	-	196M
Total Assets	-	-	-	23.12M
Germany	-	-	-	186M
Total Assets	-	-	-	216M
Total Assets	-	-	-	61.26M
Japan	-	-	-	22.1M
Total Assets	-	-	-	608K
Hong Kong	-	-	-	20.11M
Total Assets	-	-	-	652K
Australia	-	-	-	15.22M
Total Assets	-	-	-	1.08M
UK	-	-	-	10.43M
Total Assets	-	-	-	195K
Other Countries	-	-	-	10.3M
Total Assets	-	-	-	17.17M
Italy	-	-	-	9.84M
Total Assets	-	-	-	1.48M
Europe and Rest of World	164M	149M	195M	-
Total Assets	164M	208M	223M	-
Total Assets	72.91M	98.01M	86.06M	-
Asia/Pacific	48.25M	55.86M	51.92M	-
Total Assets	2.61M	3.3M	3.17M	-
North America	146M	159M	182M	-
Total Assets	34.78M	40.3M	35.35M	-